Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000584880 | SCV000582285 | likely benign | not provided | 2023-07-03 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ce |
RCV000584880 | SCV000692877 | likely benign | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765313 | SCV000896568 | uncertain significance | Brittle cornea syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000584880 | SCV002361131 | likely benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279268 | SCV002565430 | uncertain significance | Ehlers-Danlos syndrome | 2022-06-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002376906 | SCV002686212 | likely benign | Cardiovascular phenotype | 2019-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |